Skip to main content
logo
VYNE Therapeutics Inc. (VYNE)
Jul 27, 2026 - VYNE was delisted (reason: merged with YARW)
28.56
+3.11 (12.22%)
Inactive · Last trade price on Jul 27, 2026

VYNE Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21.46-26.48-39.83-28.45-23.21-73.33
Depreciation & Amortization
0.020.020-0.070.11
Loss (Gain) From Sale of Assets
----0.280.09
Loss (Gain) From Sale of Investments
-0.47-0.78-2.44-0.26--
Stock-Based Compensation
2.022.313.33.314.38.08
Other Operating Activities
---00-3.9
Change in Accounts Receivable
5.184.21-0.90.4111.217.71
Change in Inventory
----0.10.11
Change in Accounts Payable
-10.98-12.316.01-0.56-8.68-2.68
Change in Other Net Operating Assets
-0.06-0.1-0.110.21-0.35-0.37
Operating Cash Flow
-25.74-33.12-33.97-25.34-29.2-56.37
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.12---
Investment in Securities
22.2437.3723.48-62.35-1.03
Other Investing Activities
---515.67-
Investing Cash Flow
22.2437.3723.37-57.3515.671.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------36.43
Net Debt Issued (Repaid)
------36.43
Issuance of Common Stock
---82.821.4776.5
Repurchase of Common Stock
-0.07-0.14-0.14-0.07-0.03-0.29
Financing Cash Flow
-0.07-0.14-0.1482.391.6539.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-3.584.1-10.75-0.3-11.88-15.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.74-33.12-34.09-25.34-29.2-56.37
Free Cash Flow Growth
------
Free Cash Flow Margin
-5670.48%-5811.23%-6804.19%-5976.65%-6121.59%-6054.46%
Free Cash Flow Per Share
-30.08-38.73-40.02-123.34-458.25-985.78
Levered Free Cash Flow
-20.4-26.67-17-12.25-11.86-15.97
Unlevered Free Cash Flow
-20.4-26.67-17-12.25-11.86-12.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----2.39
Change in Working Capital
-5.86-8.1950.062.284.78
SEC Filings: 10-K · 10-Q